newsfilter
← Latest News
GlobeNewswire·

Decibel Therapeutics to Present at the Upcoming SVB Securities Global Biopharma Conference

BOSTON, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Decibel Therapeutics (NASDAQ:DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and